Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.

Singh V, Donini S, Pacitto A, Sala C, Hartkoorn RC, Dhar N, Keri G, Ascher DB, Mondésert G, Vocat A, Lupien A, Sommer R, Vermet H, Lagrange S, Buechler J, Warner DF, McKinney JD, Pato J, Cole ST, Blundell TL, Rizzi M, Mizrahi V.

ACS Infect Dis. 2017 Jan 13;3(1):5-17. doi: 10.1021/acsinfecdis.6b00102. Epub 2016 Sep 8.

2.

Micrococcin P1 - A bactericidal thiopeptide active against Mycobacterium tuberculosis.

Degiacomi G, Personne Y, Mondésert G, Ge X, Mandava CS, Hartkoorn RC, Boldrin F, Goel P, Peisker K, Benjak A, Barrio MB, Ventura M, Brown AC, Leblanc V, Bauer A, Sanyal S, Cole ST, Lagrange S, Parish T, Manganelli R.

Tuberculosis (Edinb). 2016 Sep;100:95-101. doi: 10.1016/j.tube.2016.07.011. Epub 2016 Jul 27.

PMID:
27553416
3.

Biosynthetic Studies of Telomycin Reveal New Lipopeptides with Enhanced Activity.

Fu C, Keller L, Bauer A, Brönstrup M, Froidbise A, Hammann P, Herrmann J, Mondesert G, Kurz M, Schiell M, Schummer D, Toti L, Wink J, Müller R.

J Am Chem Soc. 2015 Jun 24;137(24):7692-705. doi: 10.1021/jacs.5b01794. Epub 2015 Jun 15.

PMID:
26043159
4.

Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding protein.

Vidal H, Mondesert G, Galiègue S, Carrière D, Dupuy PH, Carayon P, Combes T, Bribes E, Simony-Lafontaine J, Kramar A, Loison G, Casellas P.

Cancer Res. 2003 Aug 15;63(16):4809-18.

5.

Dosage suppressors of pds1 implicate ubiquitin-associated domains in checkpoint control.

Clarke DJ, Mondesert G, Segal M, Bertolaet BL, Jensen S, Wolff M, Henze M, Reed SI.

Mol Cell Biol. 2001 Mar;21(6):1997-2007.

6.
7.

MCD4 encodes a conserved endoplasmic reticulum membrane protein essential for glycosylphosphatidylinositol anchor synthesis in yeast.

Gaynor EC, Mondésert G, Grimme SJ, Reed SI, Orlean P, Emr SD.

Mol Biol Cell. 1999 Mar;10(3):627-48.

10.

Supplemental Content

Loading ...
Support Center